ID
22465
Description
Study ID: 100273 Clinical Study ID: HS2100273 Study Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter 60-Day Study Comparing the Efficacy of Valtrex 1 Gram Once Daily vs. Placebo Once Daily in Reducing Viral Shedding in Immunocompetent Subjects with Recurrent HSV-2 Genital Herpes Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: valaciclovir Trade Name: ZELITREX,Valtrex,RAPIVIR,Novirus Study Indication: Herpes Genitalis Visit description: Genital Herpes Recurrences
Keywords
Versions (1)
- 6/5/17 6/5/17 -
Uploaded on
June 5, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Genital Herpes Recurrences
Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Genital Herpes Recurrences
Similar models
Efficacy of Valtrexin in Subjects with Recurrent HSV-2 Genital Herpes Study Genital Herpes Recurrences
C0034897 (UMLS CUI-2)
C0019342 (UMLS CUI [1,2])
C0034897 (UMLS CUI [1,3])
C0221201 (UMLS CUI [2])
C0332563 (UMLS CUI [3])
C0849001 (UMLS CUI [2,1])
C0849002 (UMLS CUI [2,2])
C0849001 (UMLS CUI [1,2])
C0849002 (UMLS CUI [1,3])
C0947323 (UMLS CUI [1,2])
C0947323 (UMLS CUI [1,2])